| Cancer | Males | Females | RR and 95% CI | RR and 95% CI |
| Colon | 1.57 (1.48, 1.65)* | 1.19 (1.04, 1.36)* | Endometrial | NA | 1.85 (1.30, 2.65)* | Esophageal | 1.23 (0.58, 2.60) | 2.04 (1.18, 3.55)* | Gallbladder | 1.47 (1.17, 1.85)* | 1.82 (1.32, 2.50)* | Leukemia | 1.16 (0.88, 1.52) | 1.32 (1.08, 1.60)* | Malignant melanoma | 1.26 (1.07, 1.48)* | 0.95 (0.84, 1.07) | Multiple myeloma | 0.58 (0.36, 0.93)* | 1.20 (0.99, 1.45) | Non-Hodgkins lymphoma | 1.09 (0.98, 1.21) | 0.91 (0.86, 0.97)* | Pancreatic | 1.36 (1.07, 1.73)* | 1.34 (1.22, 1.46)* | Postmenopausal breast | NA | 1.25 (1.07, 1.46)* | Rectal | 1.22 (0.91, 1.64) | 1.03 (0.74, 1.44) | Renal | 1.57 (1.38, 1.77)* | 1.72 (1.58, 1.88)* | Thyroid | 1.12 (0.72, 1,72) | 1.03 (0.87, 1.23) |
|
|